Fake Ozempic discovered; TGA

Test of two separate imports showed they contained no semaglutide As the Ozempic shortage continues at least until the end of June, the Therapeutic Goods Administration (TGA) has detected counterfeit imports of the sought-after diabetes and off-label weight-loss drug. According to the TGA, the products claiming to contain the active ingredient semaglutide were “being illegally

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous API breaks ground on new $50m site
Next Vale John Daffey